Key result
S-nitrosoglutathione plus thrombopoietin boosts Meg-01 platelet-sized particle production to ~48% versus thrombopoietin alone.
Why the study?
The molecular determinants of platelet formation from mature megakaryocytes remain poorly understood, despite known growth factors regulating megakaryocytopoiesis.
Nitric oxide facilitates platelet production from megakaryocytes, suggesting an essential role in thrombopoiesis.
NO may promote platelet production in megakaryocyte models; leaves open any role in human thrombopoiesis or therapy.
Although the growth factors that regulate megakaryocytopoiesis are well known, the molecular determinants of platelet formation from mature megakaryocytes remain poorly understood. Morphological changes in megakaryocytes associated with platelet formation and removal of senescent megakaryocytes are suggestive of an apoptotic process. Previously, we have established that nitric oxide (NO) can induce apoptosis in megakaryocytoid cell lines. To determine whether there is an association between NO-induced apoptosis and platelet production, we exposed Meg-01 cells to S-nitrosoglutathione (GSNO) with or without thrombopoeitin (TPO) pretreatment and used flow cytometry and electron microscopy to assess platelet-sized particle formation. Meg-01 cells treated with TPO alone produced few platelet-sized particles (<3% of total counts), whereas treatment with GSNO alone produced a significant percentage of platelet-sized particles (22 +/- 4% of total counts); when combined with TPO pretreatment, however, GSNO led to a marked increase in platelet-sized particle production (48 +/- 3% of total counts). Electron microscopy confirmed that Meg-01 cells treated with TPO and GSNO yielded platelet-sized particles with morphological features specific for platelet forms. The platelet-sized particle population appears to be functional, because addition of calcium, fibrinogen, and thrombin receptor-activating peptide led to aggregation. These results demonstrate that NO facilitates platelet production, thereby establishing the essential role of NO in megakaryocyte development and thrombopoiesis.
No takes yet. Share an insight, caveat, or question.
Battinelli et al. (2001) studied this question. S-nitrosoglutathione (GSNO) with thrombopoeitin (TPO) pretreatment vs. Thrombopoeitin (TPO) alone was evaluated on Platelet-sized particle production. S-nitrosoglutathione combined with thrombopoietin pretreatment increased platelet-sized particle production in Meg-01 cells to 48% of total counts, compared to <3% with thrombopoietin alone.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: